INTRODUCTION
Platelet-derived growth factors (PDGFs A, B, C, and D) are the key mitogens for connective tissue cells like smooth muscle cells and fibroblasts, and enhance wound healing and maintain connective tissue homeostasis in adulthood (1,2) and critically regulate embryonic development (3) (4) (5) (6) . On the other hand, healing process mediated by PDGF overexpression can occur due to inflammation or chronic injury that leads to fibrosis of pathological tissues (7) . Previous studies reported that aberrant expressions of PDGF and its receptor (PDGFR) are often associated with a variety of diseases including atherosclerosis, cancer, fibroproliferative diseases of lungs, kidneys and joints (8, 9) .
PDGF as a mitogen is composed of a family of five dimeric PDGF ligands, PDGF's A, B, C, D, and AB with two tyrosine kinase receptors, the PDGF alpha and beta (Ralpha and Rbeta) (10) . The A and B chains of PDGFs are synthesized as precursors and undergo proteolytic processing after dimerization. Ralpha and Rbeta possess 60% amino acid identity, with eight conserved cysteine residues (11) . Ralpha promiscuity may rely on its ability to bind PDGF's A, B, and C (12) , whereas Rbeta might © 1996-2015 have specificity for PDGFs B and D (13) . Although there are functional evidences for the homodimeric complexes of PDGFA-Ralpha, PDGFC-Ralpha, and PDGFB-Rbeta, some biochemical data support additional homodimeric and heterodimeric combinations (14) . In such biological context, PDGFB is produced by almost all types of solid tumors, and PDGFR signaling participates in various processes including stimulation of tumor angiogenesis, recruitment of tumor stroma fibroblasts, and autocrine stimulation of tumor cell growth (2) . In recent years, blockade of PDGFRs signaling has become an efficient therapeutic strategy against cancer (15) , and a combined inhibition of vascular endothelial growth factor (VEGF) and PDGF has emerged as a promising therapy for suppressing angiogenesis in tumor progression (16) .
The X-ray crystal structures of PDGFA and its propeptide, and PDGFB-Rbeta complexes have been reported previously (17) . However, the structural analysis of complexes Ralpha-PDGFA and Ralpha-PDGFB are unknown due to the lack of suitable crystal structure and difficulties of protein multimerization in solution (17) . Moreover, other important aspects in the interaction of complexes Ralpha-PDGFA and Ralpha-PDGFB remain unclear. Elucidating these interactions may shed light on the promiscuity and specificity related mechanisms of Ralpha and Rbeta, respectively. In this research article, protein-protein docking simulations, molecular modeling and docking validation by molecular dynamics simulation were assessed to predict the structure of Ralpha and its interaction with PDGFAXY and PDGFBXY (X and Y represent each chain). Furthermore, we analyzed the residues involved in the interaction in Ralpha-PDGFB and Rbeta-PDGFB complexes, and hypothesize possible mechanisms of Ralpha promiscuity and Rbeta specificity.
MATERIALS AND METHODS

Sequence Alignment
The primary sequence of the human Ralpha protein was obtained from the GenBank database (Accession: AAH63414). BLAST (18) was used to search suitable templates in RCSB Protein Data Bank (PDB) for the Ralpha sequence. Multiple sequence alignment (MSA) with Ralpha, Rbeta, VEGFR1 and VEGFR2 was performed by Muscle (19) . For MSA, we chose VEGFR1 (Accession: P17948) and VEGFR2 (Accession: P35968), as both shared some similarities with PDGFRs (20).
Molecular modeling and validation
The molecular modeling experiments were executed under Molecular Operating Environment (MOE) using AMBER99 force field (21) . The predicted homology model was generated using the X chain from the PDGFRbeta-PDGFB (PDB ID: 3MJG) crystal structure. Moreover, other ten intermediate models were generated and their Cartesian average was taken as the final model. The minimizations were performed with MOE until it reaches a RMSD gradient of 0.0.5 kcal mol-1Å-1. Stereochemical quality of the polypeptide backbone and side chains were evaluated using Ramachandran plot (22) , and the global score validation was calculated with QMEAN6 (23).
Protein-protein docking simulation
The crystal structures of PDGFs A and B were retrieved from PDB database (PDB ID: 3MJK; (17, 24) . The structure of PDGFA in complex with its propeptide (PDB ID: 3MJK) and Rbeta in complex with PDGFB (PDB ID: 3MJG) were chosen to assess the interacting residues for PDGFA (Y157-K160 and N134-V138) and for PDGFB (I76-K80 and R32-N36) to perform docking simulations in the ZDOCK (25) and ClusPro (26) programs. The candidate residues on the surface of interacting proteins and the experimental information on PDGFA-propeptide and Rbeta-PDGFB complexes reported previously were used to filter the docking results (17).
Docking validation by molecular dynamics simulation
The complexes Ralpha-PDGFB and Ralpha-PDGFA obtained from docking analyses were subjected to MD simulation (performed by GROMACS package v.4.5.5.) studies to refine the protein interface (27) . The two complexes were inserted into SPC solvated cubic box, and the system was neutralized by the addition of Cl-at random box, and the system was neutralized by adding Cl-at random positions in the solvent. The simulations were performed using the AMBER99 force field. Energy minimization was carried out by assessing the steepest descent method during 5000 steps with GROMACS program. MD stimulations were performed at constant pressure (1 atm) and temperature (300 K) using the Berendsen algorithm. The equilibration stage was performed with all atomic protein positions restrained during 100 ps, followed by a simulation without restraint for 10 ns. The time step used for all simulation was 2-fs (28, 29) . The final conformation was used to compute inter-residue distances, identify specific interactions at the interface and other calculations.
Docking interface analysis
Protein-protein interactions were analyzed with LigPlot+ v1.4. (30), using the DIMPLOT program for protein-protein interactions. This program shows hydrophobic and hydrogens bond interaction between proteins. Electrostatic potential surface and interaction of the complexes were calculated and represented by using Pymol v1.5.
RESULTS
We performed a search against PDB database to find suitable templates for Ralpha. Rbeta was chosen © 1996-2015 as template to model the 3D structure of the Ralpha. The BLAST results showed a 38% coverage, 32% identity and E-value of 9e-44. This 32% identity corresponded to the 3 extracellular domains (from the 23 AA to 306 AA in Ralpha), involved in the interactions with PDGFA and PDGFB. The RMSD of Ralpha and Rbeta showed low differences between the two receptors (0.5.9 Ǻ; Figure 1 ). The predicted 3D structure of Ralpha had 3 I-set Ig-like domains (D1, D2, and D3), where the binding site of the PDGFs was limited to the D2 and D3 domain ( Figure 2 ). Stereochemical quality of the built model indicated that 80.4.% of the residues lied in most favored regions and 0.4.% of the residues were in disallowed regions. The predicted model showed a global structural score of 0.6.29 and a Z-score of -1.5.3; these values suggested a correct fold of the modeled protein.
Protein-protein docking
The predicted model of Ralpha was used in a docking simulation between PDGFA (PDB code: 3MJK) and PDGFB (PDB code: 3MJG). To include only biologically relevant structures, experimental data were used from previous reported structures of Rbeta-PDGFB and PDGFA-propeptide (17) . The final docked model was also selected based on factors such as the area of surface contact, extent of interactions and stability of the model. Furthermore, the most favorable docking solution between Ralpha-PDGFA and Ralpha-PDGFB complexes were refined by MD simulation, and the structural stability of both complexes was investigated based on the root mean square deviation (RMSD). The RMSD of the backbone in Ralpha-PDGFA complex increased from 0 Å at 0 ns to ~0.5. Å at 6.5. ns, but it remained stable after 6.5. ns ( Figure 3A ). On the other hand, Ralpha-PDGFB complex reached stability after 3.5. ns ( Figure  3B ). Since complexes reached a certain structural stability at 10ns, the final conformation of two complexes in the MD simulation was selected as the final docked structure (Figure 4) . Moreover, electrostatic potential comparison of the PDGFA with Ralpha, and PDGFB with Ralpha was performed to validate whether the two complexes were electrostatically complementary in the binding area. Our results showed that the PDGFRalpha, between D2 and D3 regions, had strong negative charges (+70.7.60 kT/e and -70.7.60 kT/e; Figure 2B ) and might be electrostatically complementary to PDGFA (+67.7.96 kT/e and -67.7.96 kT/e) and PDGFB (+68.4.57 kT/e and -68.4.57 kT/e) due to the positive charges in the interacting region with Ralpha ( Figure 5 ).
The protein-protein complexes (Ralpha-PDGFA and Ralpha-PDGFB) showed that interactions were mostly hydrophobic due to the number of non-polar amino acids in the binding area such as Y, V, F, M, I, G and L (Tables 1 and 2 ). Some of these amino acids were conserved in Ralpha when interacted with PDGFA and PDGFB, and might play a key role in the hydrophobic interactions (V 155, V 242, E 241 and Y 273). Finally, the docking results were analyzed and compared with experimental data obtained from a previous study, where the 3D structure of PDGFB-Rbeta and PDGFA-propeptide complexes were reported. These comparisons were performed by using MSA (Figure 6 ).
PDGFA-Ralpha complex: interface description
Complex of PDGFA with Ralpha showed that the chains PDGFAX and PDGFAY had hydrogen bond interactions with Ralpha monomer. Nevertheless, the binding residues of both monomers in each binding site were different when in complex with Ralpha. Specifically, the residues implicated in the complex PDGFAX-Ralpha were Y 157, R 159 and N 116 (for chain X) and D 244, E 262, T 296, N 240 and V 243 (for receptor alpha; Figure 7A ). As for PDGFY-Ralpha binding, the residues were S 114, N 116, K 160, K 161 and R 159 (for chain Y) and E 262, A 295, E 298 and D 244 (for receptor alpha; Figure 7B ).
Structural analysis to assess possible hydrophobic interaction between Ralpha and PDGFA showed that a core of hydrophobic amino acid led the interaction in this complex. Moreover, the residues implicated in the complex PDGFAX-Ralpha were V 155, L 118, Figure 8B ; for a complete list see Table 1 ).
PDGB-Ralpha complex: interface description
The protein-protein interactions of this complex were mostly hydrophobic, but presented some hydrogen bond interactions as well. The residues implicated in the complex PDGFBX-Ralpha were R 79, K 80, R 27 and N 54 (for monomer X); and E 218, A 272, T 273 and V 182 (for receptor alpha; Figure 9A ). Furthermore, in the PDGFBYRalpha binding, the residues were N 34, R 32, R 28, R 27, R 79, T 101 and R 56 (for monomer Y) and A 272, L 222, E 240, Y 183 and T 160 (for receptor alpha; Figure 9B ).
Hydrophobic interactions in the PDGFB-Ralpha complex resembled to the pattern described with the PDGFA-Ralpha complex, where the binding region for the two proteins were rich in hydrophobic residues such as L, I, M, F and V. A general view of the hydrophobic interactions of the PDGFBX-Ralpha complex showed that the interacting residues were I 76, I 77, F 37, L 38 and F 84 (for monomer X) and L 222, M 110, L 138, M 137 and I 116 (for receptor alpha; Figure 10A ). As for PDGFBY-Ralpha binding, the residues were F 84, L 38, I 77 and F 37 (for monomer Y) and M 237, I 116, L 238, M 110 and L 222 (for receptor alpha; Figure 10B ; for a complete list see Table 2 ). 
DISCUSSION
In the current study, we modeled Ralpha using Rbeta (PDB ID: 3MJG) as template and performed a docking simulation of Ralpha in complex with PDGFA, and in complex with PDGFB. Using experimental data obtained from the crystallographic structure of PDGFBRbeta complex and a MSA, we identified the residues in common or those that presented substitutions between Rbeta and Ralpha in the binding area with PDGFB (M133A, N163E and N179S). These substitutions in both receptors may suggest possible mechanisms of Ralpha promiscuity and Rbeta specificity.
Our results along with the complex of PDGFA and the propeptide showed that PDGFA shared a large group of residues interacting with Ralpha and propeptide (V155, T 157, R 159, N 116, E 156, L 118, P 162, S 137, T135, N134, E90 and K160). Since Rbeta does not bind PDGFA, the interacting residues in Ralpha-PDGFA complexes were not compared. Moreover, a previous mutagenesis study of PDGFA reported that R 159, K 161 and P 162 are important residues in the interaction with Ralpha (31), and these three amino acids are also present in the interaction with PDGFA propeptide. This suggest that these residues are conserved in the interaction of PDGFA and may play an important role in the binding of other receptors associated to Ralpha, such as Ralphabeta.
Concerning the PDGFB in complex with Ralpha and Rbeta, R 27 is considered an important residue in © 1996-2015 the interaction (32). We found that N 34, R 28, R 79 and N 54 are present in the hydrogen bond formation with the above mentioned receptors, suggesting that these residues may also be linked to R 27. On the other hand, the common residues found in these receptors that interact with PDGFB were Y206Y, E241E, V242V, Y273Y and V243V. This data suggests that these residues are conserved and may play a key role in the interaction with other mitogens.
Ralpha may be activated by PDGFA, PDGFB, PDGFC and the heterodimeric PDGF-AB. On the other hand, Rbeta can be only activated by PDGFB and PDGFD (33) , suggesting that Ralpha is more promiscuous than Rbeta. It is important to clarify that Rbeta could bind other proteins such as phospholipase C gamma-1 and phosphoinositol-3-kinase (34, 35) ; nevertheless, in this paper, the specificity of Rbeta is based only in the interaction with PDGFs. Furthermore, since possible residues implicated in the interaction with PDGFB-Rbeta were previously reported (17) , and using the structural model of PDGFB-Ralpha obtained from this study, we analyzed the residues substitution that in turn could explain the specificity and promiscuity of both receptors. Our results showed that non-aromatic amino acids in Ralpha are substituted to aromatic amino acids in Rbeta D2 and D3 binding sites (I139F, L245F, L137F, P267F and N204Y). This modification has a consequence in the torsion freedom of residues interactions, thus becoming more flexible in Ralpha compared to Rbeta. Although the two aromatic amino acids L137F and P267F are absent in the complex interaction of Rbeta-PDGFB, these residues could regulate the region around and may be less exposed and flexible in the unliganded state. This observation corroborates with a previous study, which hypothesized that substitution of non-aromatic to aromatic amino acids might explain the specificity of Rbeta (17) . Hydrophobic interactions play an important role in the recognition of PDGFRs to PDGFs, but hydrogen bond formations are also significant in the specificity of protein-protein interactions (36) . Ralpha and Rbeta with PDGFB association are strongly affected by electrostatic interaction (Figure 5B ), and this condition is important in the formation of hydrogen bonds (37) . Ralpha forms eleven hydrogen bonds, while Rbeta forms fifteen hydrogen bonds when in complex with PDGFB. These outnumbered hydrogen bonds may influence the energy stability of the complex, as this hydrogen number differences may provide an extra free energy to strengthen this binding (38) . Nevertheless, an unfilled hydrogen bond donor/acceptor may destabilize the binding and avoid the interactions (37) with others PDGFs. This is more likely to occur in Rbeta, as this Figure 6 . Multiple sequence alignment of PDGFRs binding areas, with VGFR1 and VGFR2 included for comparison: In yellow are the residues changes of non-aromatics to aromatics amino acids in Rbeta. In blue are the residues with side chains able to form >4 hydrogen bond. In orange are the residues changes with a high to low probability of rotamer changes in Rbeta. receptor presents R186, D185, N244 and E241 residues, thus representing a higher number of amino acids in its structure when compared to Ralpha (E241 and E 262).
A cluster of common amino acids (M133A, N163E, N179S, K194G, K197E, M218V, N239G, Q246E, K254S, K265T, K283E, M260L, R293T and Q294E) are more likely to suffer rotamer changes in PDGFalpha in comparison to Rbeta (30-50% and 0-20%, respectively (39, 40) . These amino acid substitutions suggest that Ralpha is more able to interact with other proteins. The substitution of non-aromatic amino acids in Ralpha and energy stability of Rbeta may explain why Ralpha interacts with various PDGFs when compared to Rbeta, which only binds PDGFB and PDGFD.
The novel information here is the complete characterization of interactions between Ralpha with 
PDGFB PDGFRalpha
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